Company: BSAAR
Filing Date: 2025-05-27
Form Type: S-1/A
Source: 0001213900-25-047458
Chunk: 101

Company: BEST SPAC I Acquisition Corp.
Filing Date: 2025-05-27
Form: S-1/A
Chunk 101
---
 such time is substantially less than $10.00 per share. Upon the closing of this offering, assuming no exercise of the underwriter’s over -allotmentoption, our sponsor will have invested in us an aggregate of $2,795,000, comprised of the $25,000 purchase price for the founder shares and the $2,770,000 purchase price for the private placement units. Assuming a trading price of $10.00 per share upon consummation of our initial business combination, the 1,375,000 founder shares would have an aggregate implied value of $13,750,000. Even if the trading price of our Class A ordinary shares was as low as approximately $1.66 per share, the value of the founder shares and private placement units would be equal to the sponsor’s initial investment in us, assuming no exercise of the underwriter’s over allotment option. As a result, our sponsor is likely to be able to recoup its investment in us and make a substantial profit on that investment, even if our public shares have lost significant value. Accordingly, our management team, which is chosen by our sponsor, may have an economic incentive that differs from that of the public shareholders to pursue and consummate an initial business combination rather than to liquidate and to return all of the cash in the trust to the public shareholders, even if that business combination were with a riskier or less -establishedtarget business. For the foregoing reasons, you should consider our management team’s financial incentive to complete an initial business combination when evaluating whether to redeem your shares prior to or in connection with the initial business combination. We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us. Although we have no commitments as of the date of this prospectus to issue any notes or other debt securities, or to otherwise incur outstanding debt following this offering, we may choose to incur substantial debt to complete our initial business combination. We have agreed that we will not incur any indebtedness unless we have obtained from the 58 lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no issuance of debt will affect the per -shareamount available for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including: •default and foreclosure on our